Clinical Trials Directory

Trials / Completed

CompletedNCT01509131

Evaluation of a Mixed Bowel Prep (2L PEG + Bisacodyl) Versus PEG With Ascorbate

Low Volume Bowel Preparation for Colonoscopy: a Comparison Between PEG-CS Plus Bisacodyl Versus PEG-ASC

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
408 (actual)
Sponsor
Promefarm S.r.l. · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

It is hypothesized that PEG 2L with citrate and simeticone plus bisacodyl will have similar bowel cleansing efficacy versus PEG 2L with ascorbate. Safety, tolerability, acceptance and compliance of the two reduced volume PEG-based bowel preparation will be also compared.

Conditions

Interventions

TypeNameDescription
DRUG2L PEG-CS plus bisacodylPatients will be asked to take 2L of Lovolesse and bisacodyl (10-20 mg according to patient bowel habit)
DRUG2L PEG-ASCPatients will asked to take PEG-ASC according to labeling instructions

Timeline

Start date
2010-03-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2012-01-12
Last updated
2012-01-12

Locations

5 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT01509131. Inclusion in this directory is not an endorsement.